senicapoc has been researched along with triphenylacetic acid in 1 studies
| Studies (senicapoc) | Trials (senicapoc) | Recent Studies (post-2010) (senicapoc) | Studies (triphenylacetic acid) | Trials (triphenylacetic acid) | Recent Studies (post-2010) (triphenylacetic acid) |
|---|---|---|---|---|---|
| 42 | 3 | 32 | 6 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrington, S; Burns, JF; Creech, C; de Franceschi, L; McNaughton-Smith, GA; Rigdon, GC; Shelton, T; Stocker, JW | 1 |
1 other study(ies) available for senicapoc and triphenylacetic acid
| Article | Year |
|---|---|
Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Animals; Biological Availability; Clotrimazole; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Mice; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trityl Compounds | 2008 |